𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HUMAN T CELL RESPONSES AGAINST MELANOMA

✍ Scribed by Boon, Thierry; Coulie, Pierre G.; Eynde, Benoît J. Van den; Bruggen, Pierre van der

Book ID
120298208
Publisher
Annual Reviews
Year
2006
Tongue
English
Weight
376 KB
Volume
24
Category
Article
ISSN
0732-0582

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protective T-cell responses against tumo
Protective T-cell responses against tumours
✍ C. Melief; N. Annels; R. Dunbar; G. Forni; R. Kiessling; P. Ricciardi-Castagnoli 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 314 KB
Production of stable cytolytic T-cell cl
Production of stable cytolytic T-cell clones directed against autologous human melanoma
✍ M. Hérin; C. Lemoine; P. Weynants; F. Vessière; A. Van Pel; T. Boon; A. Knuth; R 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 721 KB

We have attempted to optimize the production of stable human cytolytic T lymphocyte clones directed against autologous melanoma cell lines. MLTC were restimulated every week with irradiated melanoma cells in medium containing human serum and IL-2. After 21 to 35 days, in 5 out of 6 patients, these c

Precursor frequency analysis of human cy
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells
✍ Pierre G. Coulie; Michel Somville; Frédéric Lehmann; Philippe Hainaut; Francis B 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 893 KB

Limiting numbers of peripheral-blood mononuclear cells (PBMC) from melanoma patients were stimulated with irradiated autologous tumor cells in the presence of interleukins-2 and -4 and in the absence of feeder cells. The responder cells were restimulated every week. After 2 to 4 weeks, the microcult

Melanoma cancer vaccines and anti-tumor
Melanoma cancer vaccines and anti-tumor T cell responses
✍ Lazar Vujanovic; Lisa H. Butterfield 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

## Abstract Melanoma is a disease which has been shown to be responsive to immune intervention. This has been suggested by reports of spontaneous responses of metastatic disease with strong immune infiltrates, and supported by recent data correlating clinical response after IFNα treatment with deve